BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8921541)

  • 1. Toxicological significance of DNA adducts: summary of discussions with an expert panel.
    Nestmann ER; Bryant DW; Carr CJ
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):9-18. PubMed ID: 8921541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adducts: endogenous and induced.
    Povey AC
    Toxicol Pathol; 2000; 28(3):405-14. PubMed ID: 10862557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.
    Sander M; Cadet J; Casciano DA; Galloway SM; Marnett LJ; Novak RF; Pettit SD; Preston RJ; Skare JA; Williams GM; Van Houten B; Gollapudi BB
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):1-20. PubMed ID: 16164957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECETOC workshop on the biological significance of DNA adducts: summary of follow-up from an expert panel meeting.
    Pottenger LH; Carmichael N; Banton MI; Boogaard PJ; Kim J; Kirkland D; Phillips RD; van Benthem J; Williams GM; Castrovinci A
    Mutat Res; 2009 Aug; 678(2):152-7. PubMed ID: 19628052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
    Poirier MC; Beland FA
    Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses.
    Lewtas J; Walsh D; Williams R; Dobiás L
    Mutat Res; 1997 Aug; 378(1-2):51-63. PubMed ID: 9288885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA adducts in model systems and humans.
    Turteltaub KW; Frantz CE; Creek MR; Vogel JS; Shen N; Fultz E
    J Cell Biochem Suppl; 1993; 17F():138-48. PubMed ID: 8412185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays.
    Paini A; Scholz G; Marin-Kuan M; Schilter B; O'Brien J; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2011 Sep; 26(5):605-18. PubMed ID: 21642616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
    Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
    Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk.
    Kriek E; Rojas M; Alexandrov K; Bartsch H
    Mutat Res; 1998 May; 400(1-2):215-31. PubMed ID: 9685648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dna adducts, mutations, and cancer 2000.
    Hemminki K; Koskinen M; Rajaniemi H; Zhao C
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):264-75. PubMed ID: 11162720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
    Booth ED; Kilgour JD; Robinson SA; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adduct burden and tobacco carcinogenesis.
    Wiencke JK
    Oncogene; 2002 Oct; 21(48):7376-91. PubMed ID: 12379880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship.
    Bartsch H
    Mutat Res; 1996 Jun; 340(2-3):67-79. PubMed ID: 8692183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.